Twice-Daily Use of Biphasic Insulin Aspart 30 (BIAsp 30): Comparative Studies A total of seven publications (three papers and four abstracts) from five studies were identified that compared twice ...
Most of the patients in this study would probably, therefore, have benefited from earlier initiation or intensification of insulin therapy. If these patients were to remain inadequately treated ...
reported interim results of a 3 year, open-label, randomized, controlled, multicenter trial comparing the efficacy and safety of adding biphasic, prandial or basal insulin to oral therapy for ...
A trial conducted in eight countries, including India has shown that using biphasic BIAsp 30 insulin can lead to significant clinical improvements and greater patient satisfaction. A trial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results